ROCKVILLE, Md. (AP) - A Rockville company will study the feasibility of a new cancer medicine with the large pharmaceutical company AstraZeneca.
CytImmune Sciences Inc. and AstraZeneca made the announcement on Thursday.
The two companies will work together to see whether they can transmit cancer drugs on extremely small gold particles.
CytImmune works in developing nanomedicine, which uses tiny particles of gold to carry cancer therapies directly to the site of the disease. The company says gold nanoparticles have been used safely since the 1930s to treat patients with rheumatoid arthritis.
Dr. Lawrence Tamarkin, CytImmune's CEO, says the partnership aims to combine CytImmune's nanotechnology research with AstraZeneca's oncology compound to create a cancer therapy that may be widely applicable to solid tumors.
Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
In the 1980s, we asked “Where’s the beef?” while these days American consumers are more interested in what the beef has been eating.
Charities virtually everywhere are asking for your generosity, but you simply cannot give to everyone.
Southwest Sullivan Schools is among the 27 school districts who will benefit from a settlement the State Secretary of State's office reached with the Indiana State Teachers Association.
The Indiana Department of Transportation (INDOT) is asking for drivers to be aware of lane restrictions on Interstate 70 through Dec. 14.
After thanksgiving many put up lights and trees to kick off the Christmas season, but there's a price tag on spreading holiday joy. One local man spoke about his large scale lighting display and just how much it's costing him.
On this nationally observed Giving Tuesday, folks in the Wabash Valley were offered reassurance their donated dollars to charities are, in fact, helping local needy families, and not being wasted on expenditures like operating costs or a …